Applied psychology

Business Leaders Speak Out for Mental Health Equity at Work

Retrieved on: 
Tuesday, October 3, 2023
Workforce, Council, Partnership, Measuring Business Excellence, Justice, Senior, Psychology, JEDI, Boston Scientific, Culture, Workplace, American Psychological Association, Headspace, Ad Council, Mental health, Applied psychology, DEIB, Creativity, Organization, National Safety Council, Stigma, Walmart, Huntsman Mental Health Institute, JD, Happiness, DEI, HAA, MPH, World Mental Health Day, Accenture, Safety, Nursing, Management, Twill, Equity, Doctor of Philosophy, Mattel

LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- In anticipation of World Mental Health Day on October 10, the Health Action Alliance (HAA) is thrilled to announce its second annual Mental Health Equity at Work Summit. This virtual event will take place on Thursday, October 5, 2023, at 2 pm ET / 11am PT. Top executives from prominent brands such as Mattel, Walmart, and Accenture, in addition to renowned mental health and diversity experts, will converge to explore the pivotal theme, "Breaking Barriers: Empowering Business Excellence through Mental Health Equity."

Key Points: 
  • LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- In anticipation of World Mental Health Day on October 10, the Health Action Alliance (HAA) is thrilled to announce its second annual Mental Health Equity at Work Summit .
  • Top executives from prominent brands such as Mattel, Walmart, and Accenture, in addition to renowned mental health and diversity experts, will converge to explore the pivotal theme, "Breaking Barriers: Empowering Business Excellence through Mental Health Equity."
  • “Forward-thinking business leaders who address the mental health needs of a diverse workforce can elevate overall well-being for their entire team.”
    “When you focus on improving mental health for those with the greatest need, everyone wins,” said Mark SooHoo, Executive Director of Health Action Alliance.
  • “Business leaders have a unique opportunity to champion the well-being of their employees, closing gaps in equitable mental health access, and ultimately driving positive business outcomes within their organizations.”
    “Mental health equity, especially considering racial battle fatigue, is crucial for a thriving workplace.

The Agency Launches New Office in Nashville, Tennessee

Retrieved on: 
Tuesday, January 24, 2023
Orphanage, University, Netflix, Financial Times, Marketing, Tunnel, Culture, Arkansas State University, Germantown High School, Real estate, Tunnel to Towers Foundation, HIIT, Partner (business rank), Partnership, The Real Housewives of Beverly Hills, Christian Brothers University, Feeding America, Sarah Kawahara, Second Harvest Toronto, Eye, Negotiation, Guild, Inman, Applied psychology, Architecture, Clothing, United States Department of the Air Force, Criminal justice, Psychology, Partner, Investment, Music, Agency

LOS ANGELES, Jan. 24, 2023 /PRNewswire-PRWeb/ -- Global real estate brokerage The Agency proudly announces the launch of its new franchise office in Nashville, Tennessee. The new locale is the firm's first office in Tennessee among its growing network of more than 70 offices in the U.S., Canada, Mexico, the Caribbean, and Europe. The Nashville office will be led by esteemed industry professionals and managing partners Scott Coggins and Amy Doyle.

Key Points: 
  • LOS ANGELES, Jan. 24, 2023 /PRNewswire-PRWeb/ -- Global real estate brokerage The Agency proudly announces the launch of its new franchise office in Nashville, Tennessee.
  • "We're thrilled to expand our footprint across the U.S. with the launch of our first office in Tennessee," said Mauricio Umansky , CEO and Founder of The Agency.
  • "Nashville is one of the most iconic destinations in the country and we're delighted to launch The Agency's first office in Tennessee in this dynamic city."
  • In the past 12 months, The Agency has showcased impressive global growth, more than 25 new corporate and independently-owned offices, including the new office in Nashville, Tennessee, with additional openings on the horizon.

Woebot Health Names Trina Histon Vice President of Clinical Product Strategy

Retrieved on: 
Wednesday, January 11, 2023
Software, Health, Mental Health, Medical Devices, Data Management, Health Technology, Technology, Apps, Applications, Psychology, University College Cork, The New England Journal of Medicine, Trust, Anxiety, Applied psychology, CMI, Psychiatry, Research, Doctor of Philosophy, Multimedia, Evidence-based medicine, Management, Medicine, Risk management, Kaiser Permanente, Health, Histon and Impington

Woebot Health today announced that it has appointed Trina Histon, PhD, as its Vice President of Clinical Product Strategy.

Key Points: 
  • Woebot Health today announced that it has appointed Trina Histon, PhD, as its Vice President of Clinical Product Strategy.
  • In the newly-created position, Histon will accelerate Woebot’s capabilities to integrate into care pathways and advance the software transformation of psychiatry, behavioral health and primary care.
  • View the full release here: https://www.businesswire.com/news/home/20230111005611/en/
    Trina Histon, PhD, Vice President of Clinical Product Strategy, Woebot Health (Photo: Business Wire)
    Histon’s expertise in embedding and deploying digital health solutions in care delivery spans more than two decades.
  • Before joining Woebot Health, Histon was a Senior Principal Consultant in Kaiser Permanente’s Care Management Institute (CMI).

Applied BioMath, LLC Announces Collaboration with SpringWorks Therapeutics, Inc. for Systems Pharmacology Modeling in Multiple Myeloma

Retrieved on: 
Tuesday, November 1, 2022
Pharmacology, Clinical pharmacology, Software, BCMA, CEO, Knowledge, Doctor of Philosophy, Cancer, Research, LLC, Industry, GSI, Nasdaq, R, Applied psychology, Disease, Therapy, Quantitative biology, Patient, Machine learning, Multiple myeloma, Engineering, Biology, B-cell maturation antigen, Biotechnology, Solution, Pharmaceutical industry, Medical device

In this collaboration, Applied BioMath is developing a model of SpringWorks' investigational oral selective small molecule gamma secretase inhibitor (GSI), nirogacestat, in combination with an agent that targets B-cell maturation antigen (BCMA) for the treatment of multiple myeloma.

Key Points: 
  • In this collaboration, Applied BioMath is developing a model of SpringWorks' investigational oral selective small molecule gamma secretase inhibitor (GSI), nirogacestat, in combination with an agent that targets B-cell maturation antigen (BCMA) for the treatment of multiple myeloma.
  • "We are pleased to work with Applied BioMath given their expertise in building systems pharmacology models for biopharmaceutical companies and we look forward to working with them to further advance our BCMA efforts."
  • Their approach involves working with clients to develop the appropriate mathematical strategy for each unique project, with common strategies encompassing systems pharmacology, mechanistic modeling.
  • Applied BioMath and the Applied BioMath logo are registered trademarks of Applied BioMath, LLC.

Applied BioMath, LLC Presents Early Feasibility Assessment for Dose Predictions at AAPS 2022 PharmSci 360

Retrieved on: 
Monday, October 17, 2022
Pharmacology, Rapid Fire, Therapy, PD, VP, Machine learning, LLC, Biotechnology, Patient, Biology, Research, R, Applied psychology, Software, Drug discovery, Doctor of Philosophy, Industry, Quantitative biology, CEO, AAPS, Manuscript, EFA, Protalix BioTherapeutics, Pharmaceutical industry

Fei Hua, PhD, VP of Modeling & Simulation Services at Applied BioMath will present Early Feasibility Assessment of Biotherapeutics Dosing Requirements during the Rapid Fire Session: Rapid Discovery of Therapeutics: Past Experience and Computational Approaches on Monday, October 17, 2022 at 3:15 p.m.

Key Points: 
  • Fei Hua, PhD, VP of Modeling & Simulation Services at Applied BioMath will present Early Feasibility Assessment of Biotherapeutics Dosing Requirements during the Rapid Fire Session: Rapid Discovery of Therapeutics: Past Experience and Computational Approaches on Monday, October 17, 2022 at 3:15 p.m.
  • In this presentation, Dr. Hua will provide an overview of Early Feasibility Assessment (EFA) and how this approach can be applied in drug discovery to help predict clinical effective dose for biotherapeutics where pharmacokinetic (PK) or pharmacodynamic (PD) data might not be available.
  • In addition to the presentation, Applied BioMath will also present the following posters at the conference:
    To learn more about Applied BioMath, visit www.appliedbiomath.com .
  • Applied BioMath and the Applied BioMath logo are registered trademarks of Applied BioMath, LLC.

Applied BioMath, LLC Announces a Continuation of their Collaboration with Celsius Therapeutics for Systems Pharmacology Modeling in Inflammatory Bowel Disease

Retrieved on: 
Tuesday, October 4, 2022
Solution, Doctor of Philosophy, CSO, Biology, Software, Research, IND, Industry, Knowledge, CEO, Quantitative biology, File, Applied psychology, LLC, Therapy, Program, Biotechnology, Machine learning, Patient, Celsius, Pharmacology, Medical device, Pharmaceutical industry

In this continued collaboration, Applied BioMath will develop an in vitro and human systems pharmacology model to support human dose predictions.

Key Points: 
  • In this continued collaboration, Applied BioMath will develop an in vitro and human systems pharmacology model to support human dose predictions.
  • Applied BioMath offers software and services to help de-risk and accelerate drug R&D.
  • "We are proud to continue working with Celsius Therapeutics to provide support for their program," said John Burke, PhD, Co-founder, President and CEO at Applied BioMath.
  • Applied BioMath and the Applied BioMath logo are registered trademarks of Applied BioMath, LLC.

Coach Mike Krzyzewski to Keynote Applied Net 2022

Retrieved on: 
Thursday, May 5, 2022
United Kingdom, National championship, Trust, USA Team Handball, Communication, National, Season, Automation, Insurance, Ireland, Sports Illustrated Sportsperson of the Year, Duke, GLOBE, Gold, Sport, Fuqua, United States national team, Organization, NBA Coach of the Year Award, Leadership, USA Basketball, Applied psychology, Republic of Ireland, Industry, AFCA Coach of the Year Award, Sports Illustrated, NCAA, International Institute for Applied Systems Analysis, Duke University, Thor Industries, Ethics, Entrepreneurship, Olympic Games, Tutoring, The New York Times

UNIVERSITY PARK, Ill., May 05, 2022 (GLOBE NEWSWIRE) -- Applied Systems and the Applied Client Network today announced that Mike Coach K Krzyzewski will be the featured keynote speaker at Applied Net 2022.

Key Points: 
  • UNIVERSITY PARK, Ill., May 05, 2022 (GLOBE NEWSWIRE) -- Applied Systems and the Applied Client Network today announced that Mike Coach K Krzyzewski will be the featured keynote speaker at Applied Net 2022.
  • This years keynote by Coach K will provide strategies and mentalities from a true winner, equipping our attendees with the tools they need to compete and win.
  • Coach K is the author of two New York Times best-sellers, including Beyond Basketball: Coach Ks Keywords for Success.
  • Coach K is also the executive-in-residence and Co-Founder at the Fuqua / Coach K Center on Leadership & Ethics at Duke University.

Applied BioMath, LLC to Present on Machine Learning in Drug Discovery at Bio-IT World Conference and Expo

Retrieved on: 
Wednesday, April 27, 2022
R, Artificial intelligence, CEO, Software, Biotechnology, LLC, Patient, Applied psychology, Quantitative biology, Machine learning, Efficiency, Conference, Therapy, AI, Multimedia, D, Research, View, Doctor of Philosophy, Pharmacology, Industry, Biology, Drug discovery, Medical device, Video game

Kas Subramanian, PhD, Executive Director of Modeling at Applied BioMath will present "Applications of Machine Learning in Preclinical Drug Discovery" within the conference track, AI for Drug Discovery and Development on Thursday, May 5, 2022 at 1:05 p.m. E.T.

Key Points: 
  • Kas Subramanian, PhD, Executive Director of Modeling at Applied BioMath will present "Applications of Machine Learning in Preclinical Drug Discovery" within the conference track, AI for Drug Discovery and Development on Thursday, May 5, 2022 at 1:05 p.m. E.T.
  • In this presentation, Dr. Subramanian will discuss how machine learning methods can improve efficiency in therapeutic R&D decision making.
  • To learn more about Applied BioMath's presence at the Bio-IT World Conference and Expo, please visit www.appliedbiomath.com/BioIT22 .
  • Applied BioMath and the Applied BioMath logo are registered trademarks of Applied BioMath, LLC.

Applied Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results

Retrieved on: 
Thursday, March 10, 2022
Heart, Nasdaq, Safety, Government, Industry, Corporation, Twitter, Accelerated approval (FDA), Private Securities Litigation Reform Act, ARI, Lists of diseases, Company, Registration, Evaluation, Authorisation and Restriction of Chemicals, Research, FDA, Diabetic cardiomyopathy, U.S. Securities and Exchange Commission, Investment, CNS, NDA, INSPIRE, UM, Intention, Applied psychology, GLOBE, Doctor of Philosophy, Patient, Central nervous system, Galactitol, Inhibitor, COVID-19, Therapy, Insurance, Investor relations, CEO, Forward-looking statement, Adult, Patent, Pharmaceutical industry, Cryptocurrency, SORD, Sorbitol, Galactosemia

NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the fourth quarter and full year ended December 31, 2021.

Key Points: 
  • NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the fourth quarter and full year ended December 31, 2021.
  • We remain committed to bringing new treatments to patients in areas of high unmet need, said Shoshana Shendelman, PhD, Founder and CEO of Applied Therapeutics.
  • Applied Therapeutics portfolio includes three Phase 3 programs for diseases with high unmet medical need and no approved treatment options.
  • A copy of the Companys February 2022 Corporate Presentation is posted to the Investor Relations section of Applied Therapeutics website.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Applied Therapeutics, Inc. (APLT) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Monday, January 31, 2022
Patient, Steve Berman (lawyer), Therapy, SAN, NASDAQ, SEC, Person, Twitter, City, Program, GLOBE, News, NDA, FDA, Newsroom, Galactosemia, Pharmaceutical industry, Applied psychology

SAN FRANCISCO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Applied Therapeutics, Inc. (NASDAQ: APLT) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Applied Therapeutics, Inc. (NASDAQ: APLT) investors with significant losses to submit your losses now .
  • The firm is investigating possible securities law violations and certain investors may have valuable claims.
  • If you invested in Applied Therapeutics and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.